Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01007071Phase 3Completed
A Phase 3 trial of somatropin in growth hormone deficiency (GHD), sponsored by Stanford University. Started Nov 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01007071.